Oral Amantadine Versus Gabapentin to Attenuate the Response to Laryngoscopy and Tracheal Intubation

Overview

To evaluate the effect of oral amantadine versus gabapentin premedication on the hemodynamic response to laryngoscopy and tracheal intubation and their effect on β-endorphins.

Full Title of Study: “Oral Amantadine Versus Gabapentin to Attenuate the Hemodynamic Response to Laryngoscopy and Tracheal Intubation and Their Effect on β-endorphin”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Prevention
    • Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
  • Study Primary Completion Date: May 15, 2018

Detailed Description

Direct laryngoscopy and passage of endotracheal tube through the larynx is a noxious stimulus, which can provoke untoward response in the cardiovascular, respiratory and other physiological systems. Gabapentin, is 1-aminomethyl cyclohexane acetic acid.Gabapentin is structurally related to the neurotransmitter gamma-aminobutyric acid (GABA). Gabapentin act in central nervous system CNS), it acts by decreasing the synthesis of neurotransmitter glutamate and by binding to the alpha 2 delta subunits of voltage dependent calcium channels. Amantadine is a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist, and compared to ketamine, it is well tolerated with fewer side effects (mainly dizziness, sedation, and dry mouth). Amantadine's formulation permits the oral route for drug delivery, as well as the IV route. The side-effects profile of amantadine via all routes seems not to be harmful in appropriate dosages.. Amantadine has been clinically used as an antiviral drug, for dementia, and in the treatment of Parkinson's disease and spasticity. It is a non-competitive NMDA receptor antagonist, and compared to ketamine, it is well tolerated with fewer side effects (mainly dizziness, sedation, and dry mouth). Amantadine's formulation permits the oral route for drug delivery, as well as the IV route. The side-effects profile of amantadine via all routes seems not to be harmful in appropriate dosages. In the central nervous system, beta-endorphins bind mu-opioid receptors and exert their primary action at presynaptic nerve terminals. However, instead of inhibiting substance P, they exert their analgesic effect by inhibiting the release of GABA, an inhibitory neurotransmitter, resulting in excess production of dopamine. The investigators designed this study to prove the efficacy of oral amantadine versus gabapentin premedication on the hemodynamic response to laryngoscopy and tracheal intubation and their effect on β-endorphins.

Interventions

  • Other: oral amantadine sulfate
    • In amantadine group:the patients will receive100 mg oral amantadine sulfate 90 minute prior to the surgery
  • Drug: oral gabapentin
    • In gabapentin group: the patients will receive oral 800 mg gabapentin 90 minute prior to the surgery
  • Drug: Placebo Oral Tablet
    • in control group : the patients will receive Placebo Oral Tablet 90 minute prior to the surgery

Arms, Groups and Cohorts

  • Active Comparator: amantadine group (Group A)
    • the patients will receive oral amantadine sulfate using the dose 100 mg 120 minutes prior to the surgery, 5 ml saline IV 5 minutes before intubation.
  • Active Comparator: gabapentin group(Group B)
    • the patients will receive oral gabapentin using the dose 800 mg 120 minutes prior to surgery,5 ml saline IV 5 minutes before intubation.
  • Placebo Comparator: control group (group C)
    • the patients will receive placebo oral tablet 120 minutes prior to surgery, IV fentanyl 2µ/kg in 5 ml saline 5 minutes before intubation.

Clinical Trial Outcome Measures

Primary Measures

  • effect of oral amantadine versus gabapentin premedication on laryngoscopy and tracheal intubation on β-endorphins.
    • Time Frame: baseline blood sample taken before drug administration and after 15 minutes after intubation and before skin incision
    • analysis of change of β-endorphins in blood sample

Secondary Measures

  • effect of oral amantadine versus gabapentin premedication on the Mean arterial blood pressure due to laryngoscopy and tracheal intubation
    • Time Frame: baselineMAP before drug administration and after 15 minutes after intubation and before skin incision
    • change of Mean arterial blood pressure
  • effect of oral amantadine versus gabapentin premedication on the heart rate due to laryngoscopy and tracheal intubation
    • Time Frame: baseline heart rate before drug administration and after 15 minutes after intubation and before skin incision
    • change of heart rate

Participating in This Clinical Trial

Inclusion Criteria

  • ASA I&II scheduled for elective spine surgery Exclusion Criteria:

  • Patient refusal – Patients with ASA score III (with chronic kidney, lungs, Gastrointestinal tract, liver, or cardiovascular diseases) – Pregnant or breastfeeding women. – Allergy to any of the study medications and taking medications that could significantly interact with amantadine (tramadol, atropine, antipsychotic medications) – diabetes mellitus, thyroid disease any endocrine disease – Suspected difficult intubation or intubation time more than 30 second.

Gender Eligibility: All

Minimum Age: 20 Years

Maximum Age: 55 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Ghada Mohammed AboelFadl
  • Provider of Information About this Clinical Study
    • Sponsor-Investigator: Ghada Mohammed AboelFadl, principal-investigator – Assiut University
  • Overall Official(s)
    • Abualauon Elpiplaoy, MD, Principal Investigator, Assiut University
    • Ahmed El shanawany, MD, Study Chair, Assiut University
    • Azza Abo Elfadl El Sayed, MD, Principal Investigator, Assiut University

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.